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Changes in the epidemiology of Haemophilus inﬂuenzae
invasive disease, in Portugal, after the introduction of the
Hib vaccine
M.P. Bajanca-Lavado ∗, C. Betencourt
National Institute of Health Dr. Ricardo Jorge, Lisbon, Por-
tugal
Background: Haemophilus inﬂuenzae (Hi) is responsi-
ble for a number of human diseases ranging from chronic
infections to meningitis. Most of the isolates are non-
encapsulated (NC), although it is known until now six
serotypes (a-f). Hi serotype b (Hib) vaccine was adopted
in Portugal since 1994 and obligated since the year 2000
to children less than ﬁve years old. Our aim is to analyse
the serotypes of Hi invasive strains in parallel with possible
changes in antimicrobial susceptibility, before and after the
introduction of vaccine.
Methods: We collected 104 invasive Hi isolates (50 CSF,
52 blood cultures and 2 pleural ﬂuids) from 1989 to 2000,
and 111 (22 CSF, 81 blood cultures and 8 pleural ﬂuids) from
2001 to 2008, from several Hospital Laboratories in Por-
tugal. Fifty two strains (50%) were isolated from children
(<18 years old) in the ﬁrst period and 34 (32.7%) after the
vaccination period. Identiﬁcation of Hi was conﬁrmed by
standard procedures. Susceptibility testing was performed
by a microdilution assay, according to the CLSI guidelines.
$-lactamase production was determined with nitroceﬁn.
Serotyping was performed by PCR.
Results: In relation to ampicillin resistance, $-lactamase
producing was detected in 28.8% of the strains in the period
1989—2000, and 12.6% between 2001-2008. Five strains
(5.2%), all isolated in the pos vaccine period, had MIC values
to ampicillin and clavulanic acid of 2mg/L, which indicates
BLNAR possible. In relation to serotype characterization, in
the pre-vaccine period, 68.3% of the strains were Hib and
31.7% were NC; after the introduction of the vaccine, 12.6%
were Hib, 79,3% NC, and 8.1% non-b-type (2.7% a and 5.4%
f).
Conclusion: Considering the two periods 1989—2000 and
2001—2008 we observe a rise in NC strains and a decline
in serotype b, in invasive disease in Portugal. Non-b-type
strains were characterized only after the introduction of
the vaccine. In this way, we document changes in invasive
infections following the introduction of the vaccine in Portu-
gal, with an emergence of NC and an increase of serotypes
other than b. We also expect a new rule in the virulence
mechanisms of these strains.
doi:10.1016/j.ijid.2010.02.1973
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Analysis of clinical outcome in patients with multidrug-
resistant Acinetobacter baumannii bacteremia
M.W. Kang ∗, Y.J. Kim, K.-W. Hong, S.I. Kim, Y.R. Kim, Y.-J.
ParkThe catholic University of Korea, Seoul, Korea, Republic of
Background: Multidrug-resistant Acinetobacter bauman-
nii (MDRAB) has been increasing reported worldwide, and
d
t
t
its e219
he therapeutic options are limited. The aim of this study
as to investigate clinical characteristic, risk factors for
ortality and outcome among patients with MDRAB bac-
eremia.
Methods: A retrospective study was performed at a ter-
iary care hospital in Korea from January 2005 to July 2009.
nly ﬁrst bacteremic episode from one patient was included
n the study. Antibiotic therapy was considered to be appro-
riate if the isolated strain was sensitive, in vitro, to initial
ntibiotic, which were administered within 48 hours after
lood culture sample obtained. Multidrug-resistant Acineto-
acter baumannii (MDRAB) was deﬁned as resistance to all
ommercially available antibiotics except colistin.
Results: Seventy-seven patients (40 male, 37 female)
ith Acinetobacter baumannii bacteremia were included.
he presumed sources of bacteremia that caused bac-
eremia were lung (n = 24,31.2%), catheter (n = 21, 27.3%),
ntraabdomen (n = 13, 17%), postoperative wound (n = 6,
.8%), urinary tract (n = 5,6.5%), and unknown (n = 8, 10.4%).
orty—three patients(55.8%) were infected with MDRAB. The
verall 30-day mortality in patients with Acinetobacter bau-
annii bacteremia was 33.7%(26/77), and was higher in
DRAB patients than non-MDRAB (62.5% vs 20.8%, p < 0.05).
ccording to univariate analysis, diabetes mellitus, central
enous catheter, mechanical ventilation, hospital day until
acteremia, inappropriate antimicrobial therapy, resistance
o imipenem and resistance to multidrug except colistin
ere associated with 30-day mortality (p < 0.05). Multivari-
te analysis using logistic regression model showed that
igniﬁcant risk factors for 30-day mortality were mechan-
cal ventilator (OR = 5.6, 95% CI 1.24-.24.83, p = 0.02), and
esistance to multidrug (OR = 40.77, 95% CI 3.95-420.85,
= 0.001).
Conclusion: Patients with MDRAB bacteremia showed
igher mortality rate than non-MDR bacteremia, although
nderlying status play an important role in clinical outcome.
he efforts to minimize the emergence of antimicrobial
esistance should be important.
oi:10.1016/j.ijid.2010.02.1974
2.017
linical proﬁle and antimicrobial resistance pattern of
nteroaggregative E.coli isolated from patients with diar-
hoea, using a multiplex PCR assay in a tertiary care
ospital in North India
. Pahil ∗, N. Taneja, G. Singh, M. Sharma
Post Graduate Institute of Medical Education and Research,
handigarh, India
Background: Enteroaggregative Escherichia coli (EAEC)
s an increasingly recognized enteric pathogen which
an cause both acute and persistent diarrhoea in chil-
ren,traveller’s diarrhoea and diarrhoea in immunocompro-
ised patients. The identiﬁcation of EAEC by conventional
echniques is technically demanding and time consuming.
he genetic and phenotypic heterogeneity also makes the
iagnosis of EAEC difﬁcult. Therefore a single assay mul-
iplex polymerase chain reaction (PCR) can be useful for
he identiﬁcation of enteroaggregative Escherichia coli. To
dentify both typical and atypical EAEC with a high sensitiv-
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ty and speciﬁcity we selected three targets including aggR,
VD432 and astA. The EAEC plasmid gene regulator, aggR
as 27.5—82% EAEC detection rate. The antiaggregation pro-
ein transporter gene, CVD432 (now aat), has a sensitivity of
5—89% and speciﬁcity of 99%. The enteroaggregative heat-
table enterotoxin gene astA has been reported in 29.8—44%
AEC strains and is most frequently detected among atypical
AEC.
Methods: Multiplex PCR was established for three genes
ggR(254 bp), CVD432(194 bp) and astAgene(94 bp). Antimi-
robial susceptibility was performed on the conﬁrmed
solates by Kirby Bauer method as recommended by CLSI.
Results: Out of a total of 185 isolates of E.coli 29%
53/185) showed presence of Enteroaggregative E.coli. Vir-
lence gene such as aggR was present in 69.8% (37/53)
solates. Genes such as east were positive in 43.3% (23/53)
f isolates and CVD was present in 56.6% (30/53) of iso-
ates.Majority of the strains were resistant to most ﬁrst line
ntibiotics showing high resistance for cotrimoxazole(84%),
moxycillin(81%) and norﬂoxacin(77%).
Conclusion: Diarrhoeagenic E.coli is a well established
ause of signiﬁcant morbidity and mortality worldwide. The
dentiﬁcation of EAEC by conventional techniques is techni-
ally demanding and time consuming. Multiplex PCR assays
argeting various virulence genes of EAEC can easily be
dopted for the routine diagnosis. In our study, 29% of cases
ere found to be caused by EAEC which were conﬁrmed
y multiplex PCR. Such a rapid technique can be extremely
seful in investigation of acute diarrhoea outbreaks due to
AEC. Drug resistance in EAEC is an increasing cause of con-
ern and most of isolates were resistant to all ﬁrst line
ntibiotics.
oi:10.1016/j.ijid.2010.02.1975
2.018
henotypic and molecular characterization of Pseu-
omonas aeruginosa isolates expressing high-level beta-
actamic resistance in cystic ﬁbrosis patients
.D.C. Batlle ∗, J. Ayala
Academy of Sciences, Havana, Cuba
Background: Most cystic ﬁbrosis (CF) patients suffers
rom chronic and fatal pulmonary infections caused by
trains of Pseudomonas aeruginosa (Ps. aeruginosa). Resis-
ance to extended spectrum Cephalosporin in this pathogen
s associated in most cases with the over production
f Cephalosporinase. The b-lactamases of Ps. aeruginosa
estroy antimicrobials with: carboxipenicilin, aminopeni-
ilin and cephalosporin The purpose of this study was to
etermine the presence of b lactamases genes (bla pse–
, ampC and bla oxa) in strains resistant. The nucleotide
equences by theses gene were determined in three resis-
ant strains to beta lactam antibiotic.
Methods: In our study 65 Ps. aeruginosa isolations were
btained from 15 cystic pediatric patients attending in
illiam Soler, in Havana during ﬁve years. Were character-zed by Micro dilution broth (MIC), Api System, Phagotyping
nd serotyping and Pulse Field gel Electrophoresis. High
evel Ceftazidime resistant isolate were conﬁrmed by PCR
etection of bla pse–1, ampC and bla oxa gene. Ampliconsternational Congress on Infectious Diseases (ICID) Abstracts
esulting from PCR determining regions of these genes were
uriﬁed with a Quia Quick spin PCR puriﬁcation kit. The
ucleotide sequences were determined with an automatic
equencer ABI PRISM 377 DNA SECUENCER.
Results: Mutations in the beta lactam resistance deter-
ining region of the ampC gene were detected in 3 strains
eftazidime resistant. Higth level by MIC to Ticarcillin,
ztreonam and Ceftazidime was associated with mutations
t codon 180 and 195 of the AmpC gene. The codon 180
mino acid change Pro to Arg and the codon 195 the
minoacid change Glu to Lys in the three strains. The
pidemiological date indicated that such resistant strains
robably emerge independently, possibly following selection
uring treatment with beta lactam drug.
Conclusion: Two main clusters were detected by PFGE
n our study, with common clonal relation among strains
iperacillin, Tobramicin and Meropenem were active against
ost of the strains tested, and is a good choice of antibac-
erial drug for treating CF infections. The results this work
ill be very helpful to guide empirical antimicrobial therapy
nd the implementation of infection control in cystic ﬁbrosis
atients in our country.
oi:10.1016/j.ijid.2010.02.1976
2.019
pigenetic regulation of lymphocytes response to LPS
. Melo1,∗, M. Camargo2, R. Curi 2, I. Velasco1, F. Soriano1
Medicine school University of Sao Paulo, Sao Paulo, Sao
AULO, Brazil
ICB University of Sao Paulo, Sao Paulo, Sao PAULO, Brazil
Background: Recent evidence suggests that many inﬂam-
atory genes are regulated by epigenetic modiﬁcations to
ndividual promoters. This level of control allows a single
ene to be expressed or silenced according to its func-
ion and to the previous conditions suffered, irrespective
f other genes induced by the same receptor, and therefore
s ‘‘gene-speciﬁc’’. The aim of the study is analyze in LPS
olerance the epigenetic via used to regulate gene expres-
ion (demethylation or hypermethylation) in lymphocytes
esponse.
Methods: Lymphocytes were cultured in DMEM (con-
rol C). Tolerance was reproduced in culture lymphocytes
xposed to LPS (T group) (24 and 48 h). NAB or 5aza were
dded once (NAB1 and 5aza1) for 24 h. After this period
PS was added to the media. The production of IL-6, IL-
0, IL-1, TNF, and MIP-2 were measured by enzyme-linked
mmunosorbent assay (ELISA). RT-PCR was performed to ver-
fy the differential mRNA expression. Primer sequences were
esigned using GenBank (www.ncbi.nlm.nih.gov).
